Court Rules
All enforcement actions
Administrative OrderLow RiskMultistate

NJ Bureau of Securities Orders Hedge4.ai to Halt AI Crypto Scam

Horatiu Charlie Caragaceanu, The Shark of Wall Street, and Hedge4.aiMay 10, 2023New Jersey Attorney General

Summary

The New Jersey Bureau of Securities issued a Cease and Desist Order against Horatiu Charlie Caragaceanu and his organizations for promoting TruthGPT Coin, a cryptocurrency scam that falsely claimed AI capabilities and endorsements from figures like Elon Musk. The respondents misrepresented the AI model's ability to predict cryptocurrency prices and manipulated images to show false endorsements, targeting investors with unrealistic profit promises.

Remedy

The Cease and Desist Order requires the respondents to immediately stop promoting, offering, and selling TruthGPT Coin and other unregistered securities in New Jersey.

Injunction

Contract Impact

In-house legal teams should review all vendor, customer, and marketing agreements where the company promotes AI-driven financial products or services, particularly those involving cryptocurrency or investment offerings. Specific clauses to scrutinize include representations and warranties regarding AI functionality and predictive accuracy, endorsement and testimonial clauses (to ensure proper consent and avoid fabricated endorsements), marketing and advertising compliance provisions, and risk disclosure requirements. Agreements with third-party promoters or influencers should be examined for clauses requiring verification of claims and prohibiting false endorsements. Recommended changes include adding explicit disclaimers that AI models do not guarantee investment returns, implementing pre-approval processes for any endorsements or testimonials, and strengthening audit rights to verify compliance with advertised AI capabilities.

Contract Search Terms

AI capability warrantiescrypto asset representationsendorsement disclaimersinvestment suitability clausesrisk disclosure requirementsfalse advertising clausesmaterial misrepresentation prohibitionspromoter affiliation disclosures

Violation Types

Entity Details

Entity

Horatiu Charlie Caragaceanu, The Shark of Wall Street, and Hedge4.ai

Also known as: Hedge4.ai

Industry

Financial Services

Official Sources

Source Evidence

Entity Name
"Horatiu Charlie Caragaceanu and his organizations, The Shark of Wall Street and Hedge4.ai (collectively, “Respondents”)."
Violation Types
"promoting TruthGPT Coin, a cryptocurrency that purportedly uses an artificial intelligence model called Elon Musk AI."
Violation Types
"According to the Cease and Desist Order, the Respondents are misrepresenting Elon Musk’s endorsement of TruthGPT Coin, and they are manipulating animated avatars and images of Elon Musk to falsely demonstrate his endorsement."
Is Multistate
"The Bureau issued the enforcement action in coordination with several states bringing actions against Horatiu Charlie Caragaceanu and his organizations."

Related Enforcement Actions

NJ

Trump Administration

A multistate coalition co-led by New Jersey won a federal court order rejecting the Trump Administration’s decision not to request funding for the CFPB. The order struck down that decision and directed the Administration to follow the law and fund the agency; no monetary penalty or privacy violation is described.

NJ

Mitragynine pseudoindoxyl, MGM-15, and MGM-16

New Jersey’s Attorney General and Division of Consumer Affairs alerted the public that three synthetic kratom-related compounds became illegal to possess or sell in the state under a temporary federal scheduling order. The release describes a controlled-substance alert, not a privacy enforcement action, and identifies no company, privacy violation, or monetary penalty.

NJ

Laboratory Corporation of America Holdings (LabCorp)

$2.3M

Laboratory Corporation of America Holdings agreed to pay $2,287,455 to participating states and strengthen its security and vendor-management practices following an investigation into the 2019 breach at its debt-collection vendor, AMCA. The breach potentially exposed information of more than 27.5 million people nationwide, including sensitive information belonging to approximately 10.2 million LabCorp patients.

NJ

Credit Acceptance Corporation (CAC)

$694.0M

New Jersey's Attorney General and Division of Consumer Affairs, along with 41 Attorneys General, reached a $694 million settlement with subprime auto lender Credit Acceptance Corporation over allegations it originated unaffordable loans its own systems predicted borrowers could not repay, employed aggressive debt-collection tactics, and failed to prevent deceptive vehicle-service contract and GAP product 'packing' by dealers. The multistate settlement stepped in after the CFPB permanently dropped its 2023 enforcement action against CAC in 2025. CAC will provide $60 million in cash restitution, $634 million in debt relief, an additional $15 million to the states, and implement injunctive lending reforms including loan off ramps, pre-loan disclosures, add-on packing safeguards, and a seven-year vehicle price cap. Note: this is a consumer-protection lending enforcement action, not a privacy matter; violation categories are best-fit mappings from the available taxonomy.

NJ

Match Group, Inc.

$650K

The New Jersey Attorney General and Division of Consumer Affairs announced that Match Group, Inc. will pay $650,000 and change its business practices to settle allegations that it misrepresented or failed to disclose its criminal background screening policies and practices to New Jersey users, violating the New Jersey Consumer Fraud Act and the Internet Dating Safety Act. Under a Consent Order, Match must accurately represent its screening policies, notify existing New Jersey members of updated disclosures within 150 days, and post clear and conspicuous disclosures and safety notifications about the limitations of criminal background screenings.

NJ

Glenmark, Lannett, Bausch, Apotex, Heritage, and Emcure

$96.5M

New Jersey and a coalition of states and territories obtained preliminary approval for a plan to distribute funds from settlements with generic drug manufacturers accused of conspiring to raise drug prices. The settlements total approximately $96.5 million, and eligible consumers may submit claims for compensation.